Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Gea claims antiplatelet and fibrinolytic compounds

June 7, 1996

PharmaGenics discloses oligonucleotides

June 7, 1996

Thrombin inhibitors claimed by Boehringer Mannheim

May 31, 1996

Tirofiban advances through clinical trials; filing in sight

May 24, 1996

IND filing anticipated for TBC-1269

May 24, 1996

VCAM-1/VLA-4 inhibitors in the Texas Biotechnology pipeline

May 24, 1996

Fibrinogen antagonists claimed by Taisho

May 24, 1996

Mitsui Toatsu reports bicyclic fibrinogen antagonists

May 24, 1996

E. Merck claims oxazolidinone adhesion receptor antagonists

May 24, 1996

NovoSeven Spanish introduction imminent

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...